Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$1.70
-0.1%
$1.83
$1.26
$5.46
$63.49M0.0298,344 shs1,677 shs
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
$0.14
+45,566.7%
$0.17
$0.00
$3.40
$14.15M-17.745,371 shsN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.46
+1.7%
$2.49
$2.07
$3.80
$75.36M0.5939,762 shs43,010 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.73
-0.2%
$4.68
$4.01
$9.33
$77.79M1.32194,832 shs55,435 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.00%-0.70%-5.67%-22.47%-67.69%
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
+45,566.67%+45,566.67%-32.35%-11.61%-31.53%
InspireMD, Inc. stock logo
NSPR
InspireMD
0.00%+6.03%+7.89%-10.22%-10.22%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-1.66%+1.07%+0.42%-8.33%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
1.8119 of 5 stars
3.23.00.00.00.61.70.6
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/AN/AN/AN/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
2.3764 of 5 stars
3.52.00.00.01.52.50.6
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.4367 of 5 stars
3.62.00.00.01.70.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
2.33
Hold$8.50400.59% Upside
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
0.00
N/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5082.93% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67146.65% Upside

Current Analyst Ratings Breakdown

Latest HYBT, EDAP, NSPR, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/15/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
4/4/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$8.00 ➝ $2.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/28/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$5.00 ➝ $4.50
3/28/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00 ➝ $19.00
(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$69.18M0.92N/AN/A$1.18 per share1.44
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
$80K176.81N/AN/A$0.38 per share0.36
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M10.72N/AN/A$1.83 per share1.34
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.86$0.43 per share10.95$3.41 per share1.39
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$20.58M-$0.62N/AN/AN/A-34.45%-51.42%-26.43%8/27/2025 (Estimated)
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
-$270KN/A0.00N/A-453.55%-6.43%-4.43%N/A
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1047.3020.57N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest HYBT, EDAP, NSPR, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$0.16-$0.20-$0.04-$0.20$16.56 million$16.37 million
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
3/27/2025Q4 2024
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$0.11-$0.05+$0.06-$0.05$20.83 million$22.69 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
N/AN/AN/AN/AN/A
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.10
1.74
1.21
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/A
0.35
0.34
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
62.74%
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/A
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.23%
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
89.24%
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
23037.39 million37.31 millionOptionable
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
6103.25 million11.11 millionNot Optionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

EDAP TMS stock logo

EDAP TMS NASDAQ:EDAP

$1.69 -0.01 (-0.59%)
As of 06/20/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

Heyu Biological Technology stock logo

Heyu Biological Technology OTCMKTS:HYBT

$0.14 +0.14 (+45,566.67%)
As of 06/20/2025

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.46 +0.04 (+1.65%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$2.44 -0.02 (-0.81%)
As of 06/20/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.73 -0.01 (-0.21%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$4.71 -0.02 (-0.42%)
As of 06/20/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.